Dementia as a manifestation of neurolupus: Two cases;Neurolupus a manifestations dementielles. Deux cas

Revue Neurologique

Volumn 153, Issue 6-7, 1997, Pages 398-405

  Camdessanche, J P ^a   Michel, D ^a   Cathebras P ^b   Thomas Anterion C ^a   Antoine, J C ^a   Barral, F G ^a   Rousset, H ^b  

^a SERVICE DE NEUROLOGIE   (France)

^b HÔPITAL NORD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYAMEMAZINE; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; PREDNISONE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CASE REPORT; DEMENTIA; FEMALE; HUMAN; LUPUS VULGARIS; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; CYCLOPHOSPHAMIDE; DEMENTIA; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREDNISONE;

EID: 0030860022     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. ALEXANDER G.E., CRUTCHER M.D. (1990). Functional architecture of basal ganglia circuits: neural substrates of parallel processing. TINS, 13, no 7 : 266-271.
2. BLUESTEIN H.G., WILLIAMS G.W., STEINBERG A.D. (1981). Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus (SLE). Am J Med, 70 : 240-246.
3. BOUMPAS D.T., YAMADA H., PATRONAS N.J., SCOTT D, KLIPPEL J.H., BALOW J.E. (1991). Pulse cyclophosphamide for severe neuropsychiatric lupus. Quarterly J Med, 296 : 975-984.
4. CARBOTTE R.M., DENBURG S.D., DENBURG J.A. (1986). Prevalence of cognitive impairment in systemic lupus erythematosus. J Nerv Ment Dis, 174 : 357-364.
5. CLARK E.G., BAILEY A.A. (1956). Neurological and psychiatric signs associated with systemic lupus erythematosus. JAMA, 160 : 455-457.
6. CUMMINGS J.L. (1993). Frontal-subcortical circuits and human behavior. Arch Neurol, 50 : 873-880.
7. DENBURG J.A., BEHMANN S.A. (1994). Lymphocyte and neuronal antigens in neuropsychiatric lupus: presence of an elutable immunoprecipitable lymphocyte/neuronal 52 kd reactivity. Ann Rheum Dis, 53 : 304-308.
8. DENBURG J.A., CARBOTTE R.M., DENBURG S.D. (1987). Neuronal antibodies and cognitive function in SLE. Neurology, 37 : 464-467.
9. DEVINSKY O., PETITO C.K., ALONSO D.R. (1988). Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol, 23 : 380-384.
10. ELLIS S.G., VERITY M.A. (1979). Central nervous system involvement in systemic lupus erythematosus. Semin Arthritis Rheum, 8 : 212-221.
11. ESTES D., CHRISTIAN C.L. (1971). The natural history of systemic lupus erythematosus by prospective analysis. Medicine, 50 : 85-95.
12. FEINGLASS E.J., ARNETT F.C., DORSCH C.A., ZIZIC T.M., STEVENS M.B. (1976). Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum and relationship to other features of the disease. Medicine, 55 : 323-339.
13. FLECHTNER K.M., BAUM K. (1994). Mixed connective tissue disease: recurrent episodes of optic neuropathy and transverse myelopathy. Successful treatment with plasmapheresis. J Neurol Sc, 126 : 146-148.
14. FUTRELL N., SCHULTZ L.R., MILLIKAN C. (1992). Central nervous system disease in patients with systemic lupus erythematosus. Neurology; 42 : 1649-1657.
15. HANLY J.G., FISK J.D., SHERWOOD G., JONES E., JONES J.V., EASTWOOD B. (1992). Cognitive impairment in patients with systemic lupus erythematosus. J Rheumatol, 19 : 562-567.
16. HANLY J.G., WALSH N.M.G., SANGALANG V. (1992). Brain pathology in systemic lupus erythematosus. J Rheumatol, 19 : 732-741.
17. HAY E.M., HUDDY A., BLACK D., MBAYA P., TOMENSON B., BERNSTEIN R.M., HOLT P.J.L., CREED F. (1994). A prospective study of psychiatric disorder and cognitive function in systemic lupus erythematosus. Ann Rheum Dis, 53 : 298-303.
18. ISSHI K., HIROHATA S. (1996). Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum, 39 : 1483-1490.
19. IVERSON G.L. (1993). Psychopathology associated with systemic lupus erythematosus: a methodological review. Semin Arthritis Rheum, 22 : 242-251.
20. JOHNSON R.T., RICHARDSON E.P. (1968). The neurological manifestations of systemic lupus erythematosus. A clinical-pathological study of 24 cases and review of the literature. Medicine ; 47 : 337-369.
21. KALLENBERG C.G.M. (1994). Overlapping syndromes, undifferentied connective tissue disease, and other fibrosing conditions. Current Opinion in Rheumatology, 6 : 650-654.
22. e éd. Flammarion, 1, Paris, pages 545-556.
23. KIRK A., KERTESZ A., POLK M.J. (1991). Dementia with leucoencephalopathy in systemic lupus erythematosus. Can J Neurol Sci, 18 : 344-348.
24. KLUGER A., GOLDBERG E. (1990). IQ patterns in affective disorder, lateralized and diffuse brain damage. J of Clin and Experiment Neuropsychology, 12 : 182-194.
25. KODAMA K., OKADA S., HINO T., TAKABAYASHI K., NAWATA Y., UCHIDA Y., YAMANOUCHI N., KOMATSU N., IKEDA T., SHINODA N., MURAKAMI A., SAKAMOTO T., SATO T. (1995). Single photon emission computed tomography in systemic lupus erythematosus with psychiatric symptoms. JNNP, 58 : 307-311.
26. KOPELMAN M. (1986). Clinical tests of memory. Br J Psy, 148 : 517-525.
27. LIEM M.D., GZESCH D.J., FLANDERS A.E. (1996). MRI and angiographic diagnosis of lupus cerebral vasculitis. Neuroradiology, 38 : 134-136.
28. LOUARN F., MAS J.L., DEGOS J.D. (1984). Atteinte du système nerveux central au cours du LED. Rev Neurol, 140 : 110-116.
29. MICHEL D., LAURENT B. (1996). Neurobehavioural and neuropsychiatric stroke syndromes. Current Review of Cerebrovascular Disease; Fisher M., Bogousslavsky. J. Current Medicine : 41-58.
30. MINI DSM-IV. American Psychiatric Association. Critères diagnostiques. (Washington DC, 1994).
31. NOJIMA Y., MINOTA S., YAMADA A., TAKAKU F., AOTSUKA S., YOKOHARI R. (1992). Correlation of antibodies to ribosomal P protein with psychosis in patients with systemic lupus erythematosus. Ann Rheum Dis, 51 : 1053-1055.
32. ROBIN C., GONNAUD P.M., DURIEU I., CROISILLE B., GARASSUS P., LEVRAT R., CHAZOT G., AIMARD G., TRILLET M. (1995). Démence lupique progressive. Deux cas avec anticorps antiphospholipides ou non. Rev Neurol, 12 : 699-707.
33. SCHINDER A., BASSETTI C., GUTBROD K., OZDOBA C. (1995). Very severe amnesia with acute onset after isolated hippocampal damage due to systemic lupus erythematosus. JNNP, 59 : 644-646.
34. TAN E.M., COHEN A.S., FRIES J.F., MASI A.T., Mc SHANE D.J., ROTHFIELD N.F., SCHALLER J.G., TALAL N., WINCHESTER R.J. (1982). The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 25 : 1271-1277.
35. TEH L.S., HAY E.M., AMOS N., BLACK D., HUDDY A., CREED F., BERNSTEIN R.M., HOLT P.J.L, WILLIAMS B.D. (1993). Anti-P antibodies are associated with psychiatric and focal cerebral disorder in patients with systemic lupus erythematosus. Br J Rheum, 32 : 287-290.
36. VAN DAM A.P., WEKKING E.M., CALLEWAERT J.A.C., SCHIPPERIJN A.J.N., OOMEN H.A.P.C., DE JONG J., SWAAK A. J.G., SMEENK R.J.T., FELTKAMP T.E.W. (1994). Psychiatric symptoms before systemic lupus erythematosus is diagnosed. Rheumatol Int, 14 : 57-62.
37. WARD M.M., STUDENSKI S. (1991). The time course of acute psychiatric episodes in systemic lupus erythematosus. J Rheumatol, 18 : 535-539.